Skip to main content
Thomas Leblanc, MD, Oncology, Durham, NC

ThomasWilliamLeblancMDMA, MHS, FAAHPM

Oncology Durham, NC

Hematologic Oncology, Hospice & Palliative

Associate Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy

Dr. Leblanc is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leblanc's full profile

Already have an account?

  • Office

    2400 Pratt Street
    Durham, NC 27710
    Phone+1 919-684-8964

Summary

  • Dr. Thomas Leblanc is an oncologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from Duke University School of Medicine and has been in practice 11 years. He specializes in hematologic oncology and palliative medicine, and is experienced in acute leukemias (AML, ALL) and myeloid malignancies, including MDS, CML, CMML, and related myeloproliferative neoplasms including ET, PV, and MF, as well as rarer diseases like BPDCN He has authored more than 200 publications with over 500 citings.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hospice and Palliative Medicine, 2011 - 2012
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2010
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2006 - 2009
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2025
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha
  • Research Scholar Award American Academy of Hospice and Palliative Medicine
  • Junior Career Development Award Grant National Palliative Care Research Center (NPCRC)

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia  
    Areej El-Jawahri, Thomas W Leblanc, Selina M Luger, Bhavana Bhatnagar, Alison R Walker, Amir T Fathi, Andrew M Brunner, Gabriela S Hobbs, Jennifer S Temel, JAMA Oncology
  • The Experiences of Older Caregivers of Cancer Patients Following Hospital Discharge  
    Richard F Riedel, Ellen Mahoney, Thomas W LeBlanc, Cristina C Hendrix, Supportive care in cancer
  • Transfusion Dependence, Use of Hospice Services, and Quality of End-of-Life Care in Leukemia  
    Thomas Leblanc, MD, Blood

Abstracts/Posters

  • Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Real-World Treatment Patterns and Overall Survival Among Medicare Fee-for-Service Beneficiaries Newly Diagnosed with Peripheral T-Cell Lymphoma
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Cancer-Related Distress and Unmet Needs Among Acute Myeloid Leukemia Survivors
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A video decision aid to improve acute myeloid leukemia patients’ illness understanding: Results of a pilot trial. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Prognostic Understanding in Cancer Care: How Well Do Patients Understand Their Illness? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual Meeting
    Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual MeetingDecember 1st, 2021
  • Sorsogon’s Deaf and Blind School Children to Benefit from PHL-US 1st Inclusive Education Center
    Sorsogon’s Deaf and Blind School Children to Benefit from PHL-US 1st Inclusive Education CenterFebruary 26th, 2020
  • & # 39; How Much Time Do I Have? & # 39; New Online Tool for Cancer Patients
    & # 39; How Much Time Do I Have? & # 39; New Online Tool for Cancer PatientsFebruary 3rd, 2020
  • Join now to see all

Professional Memberships